Divis Labs share price Down ▼-3.29% on 05-Aug-2024

Divis Labs share price slump ▼-3.29% on 05-Aug-2024. | 1.45m shares traded.
Its CMP is Rs 4826.95 and M Cap is approx : 1.3 Lack Crores.
The stock is up ▲ 0.8% in 7 days,
up ▲ 4.3% in 1 month
and up ▲ 7.2% in 2 months.
Please click image for Latest Daily data.
Divis Labs Results Mar 2024 (Standalone_YoY) revenue elevated to 2259 crores up 18% in Mar 2024 quarter, compared with 1908 crores in Mar 2023. Its Net profit is 531 crores up 66% in Mar 2024 quarter, compared with 319 crores in last year same quarter. Please click Image for Daily Data and Results of the stock.
* Data updated everyday at 7pm. Only Data. Not Buy or Sell advice.

Click Image for Data | Scroll down for Comments

About Divis Labs :

Founded: 12 October 1990
Founder: Murali Divi
Headquarters: India
Number of employees: 8,433 (2023)
Revenue: 9,073 crores INR (US$1.1 billion, 2022)
Subsidiaries: Divi’s Laboratories Europe AG, Divis Laboratories (USA), Inc.

Divi’s Laboratories Limited is an Indian pharmaceutical company that manufactures active pharmaceutical ingredients (APIs) and intermediates. The company was founded in 1990 as Divi’s Research Centre, and changed its name to Divi’s Laboratories Limited in 1994.

Divi’s Laboratories is headquartered in Hyderabad and offers products to more than 95 countries. The company manufactures generic APIs, nutraceutical ingredients, and custom synthesis of APIs for Big Pharma. Divi’s is a leading manufacturer of generic APIs in the world, currently offering over 25 products commercially.

Divi’s Laboratories has subsidiaries including Divis Laboratories (USA), Inc. and Divi’s Laboratories Europe AG.
—————————————————-
* About company information is from various sources on the internet ( March 2024 ).
Please verify the official website of company for the latest updated information.
—————————————————-

Please visit